Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.
D003520:Cyclophosphamide / Q000009:adverse effects*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D012306:Risk; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced*
D003520:Cyclophosphamide